|
Real-time Estimate
Cboe Europe
06:09:16 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 12,530.00 GBX | +1.87% |
|
+5.16% | -9.31% |
| 06:05am | AstraZeneca strikes $40 million AI drug discovery deal with insitro | RE |
| 10-14 | FTSE 100 closes higher despite hot US inflation | AN |
| Market Cap | 251B 226B 210B 191B 358B 23,874B 360B 2,526B 986B 12,391B 942B 921B 39,852B | P/E 2026 * |
21.1x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 271B 243B 227B 206B 387B 25,772B 389B 2,727B 1,065B 13,376B 1,017B 995B 43,019B | EV / Sales 2026 * |
4.27x | EV / Sales 2027 * | 3.91x |
| Free-Float |
96.62% | Yield 2026 * |
2.07% | Yield 2027 * | 2.19% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | +1.85% | ||
| 1 week | +5.16% | ||
| Current month | +1.84% | ||
| 1 month | +3.21% | ||
| 3 months | -0.48% | ||
| 6 months | -15.31% | ||
| Current year | -9.31% |
| 1 week | 11,816 |  | 12,512 |
| 1 month | 11,716 | | 12,788 |
| Current year | 10,524 | | 15,732 |
| 1 year | 10,524 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,090.32 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Pam Cheng
COO | Chief Operating Officer | 55 | 2015-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/6/26 | Free | See remarks | 2 | 0.0000% | - | |
| 9/14/26 | Free | Chief Financial Officer | 73 | 0.0000% | ||
| 9/14/26 | Buy | Chairman | 2,500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.87% | +5.16% | -1.10% | +13.98% | 251B | |
| +3.62% | +1.68% | +48.80% | +98.41% | 1,077B | |
| +2.13% | -1.76% | +33.04% | +61.88% | 612B | |
| +3.32% | +4.47% | +23.72% | +91.59% | 501B | |
| +3.80% | +3.21% | +73.99% | +41.69% | 364B | |
| +0.65% | +5.81% | +31.36% | +48.01% | 353B | |
| +0.90% | +5.05% | +18.86% | +41.81% | 278B | |
| +3.21% | +3.15% | +45.01% | +49.99% | 230B | |
| +3.80% | +4.56% | +29.59% | +97.73% | 190B | |
| +0.73% | +3.20% | -29.13% | -63.52% | 168B | |
| Average | +1.88% | +1.85% | +27.41% | +48.16% | 402.49B | |
| Weighted average by Cap. | +1.71% | +1.55% | +34.46% | +63.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.39B 56.99B 53.19B 48.2B 90.5B 6,032B 91.06B 638B 249B 3,131B 238B 233B 10,069B | 67.27B 60.49B 56.45B 51.16B 96.05B 6,402B 96.65B 677B 265B 3,323B 253B 247B 10,687B |
| Net income | 11.81B 10.61B 9.91B 8.98B 16.85B 1,123B 16.96B 119B 46.42B 583B 44.32B 43.36B 1,875B | 13.73B 12.34B 11.52B 10.44B 19.6B 1,307B 19.72B 138B 53.98B 678B 51.54B 50.43B 2,181B |
| Net Debt | 19.94B 17.93B 16.73B 15.16B 28.47B 1,898B 28.65B 201B 78.4B 985B 74.87B 73.24B 3,168B | 12.31B 11.06B 10.32B 9.36B 17.57B 1,171B 17.68B 124B 48.38B 608B 46.2B 45.2B 1,955B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | GBX 12,506.00 | +1.67% | 365,378 |
| 26-10-14 | GBX 12,300.00 | +3.40% | 2,182,103 |
| 26-10-13 | GBX 11,896.00 | -1.08% | 2,152,485 |
| 26-10-12 | GBX 12,026.00 | +0.23% | 1,751,378 |
| 26-10-09 | GBX 11,998.00 | +0.89% | 4,458,670 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
